Infusion reactions, also known as acute infusion reactions or infusion-related reactions, are common adverse effects that can occur when a person receives medication intravenously. Infusion reactions ...
Pre-medication regimen showed an infusion-related reaction rate of 22.5 percent with intravenous RYBREVANT ®, a three-fold reduction from 67.4 percent historically seen with standard IRR management ...
Briumvi (ublituximab-xiiy) is a prescription drug used to treat certain types of multiple sclerosis (MS). Briumvi can cause side effects that range from mild to serious. Examples include upper ...
Sociodemographic Inequities in Telemedicine Use Among US Patients Initiating Treatment in Community Cancer Centers During the Ongoing COVID-19 Pandemic, 2020-2022 Based on our observations, it is ...
Fabrazyme (agalsidase beta) is a brand-name intravenous (IV) infusion that’s prescribed for Fabry disease in adults and certain children. As with other drugs, Fabrazyme can cause side effects, such as ...
For people living with primary immunodeficiency (PI), immunoglobulin replacement therapy is an essential part of preventing serious infections. The treatment can be delivered through an IV ...
Kisunla (donanemab-azbt) is a prescription drug used to treat Alzheimer’s disease. Kisunla can cause side effects that range from mild to serious. Examples include headache and infusion-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results